GlassScriptPhysician profile
Linda Lee
NPI 1043691447
$5,184.61
in general payments reported to CMS, 2019-2025
19 companies · $2,511 in 2025
The $2,511 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $482 · 2021: $200 · 2022: $383 · 2023: $289 · 2024: $969 · 2025: $2,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,356 · Food and Beverage: $1,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,356.06 |
| Food and Beverage | $1,412.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,780.41 | 2019-2025 | Triclip, Navitor, Mitraclip |
| Edwards Lifesciences Corporation | $982.50 | 2020-2024 | Pascal, Evoque |
| Janssen Pharmaceuticals, INC | $238.83 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $229.82 | 2020-2023 | Brilinta |
| Pfizer INC. | $175.33 | 2020-2023 | |
| Amgen INC. | $157.89 | 2019-2022 | |
| Boston Scientific Corporation | $149.13 | 2020 | |
| Lantheus Medical Imaging, INC. | $89.09 | 2020-2023 | Definity |
| Novartis Pharmaceuticals Corporation | $75.45 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.66 | 2019-2023 | Lifevest |
| Cardiva Medical, INC. | $43.98 | 2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs |
| Merck Sharp & Dohme LLC | $43.52 | 2022-2023 | Verquvo |
| Siemens Medical Solutions USA, INC. | $29.34 | 2024 | Acuson Origin Diagnostic Ultrasound System |
| Abiomed | $28.06 | 2020 | |
| Terumo Medical Corporation | $24.62 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $24.47 | 2019 | |
| Medtronic, INC. | $19.68 | 2021 | |
| Heartflow, INC. | $17.21 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.